Pharmaceutical composition for treatment of soft tissue injuries

Abstract

Belonging to the technical field of medicine, the invention discloses a pharmaceutical composition for treatment of soft tissue injuries. The pharmaceutical composition comprises the following components by weight: 16-20 parts of Chinese angelica, 16-20 parts of Ligusticum wallichii, 7-11 parts of panax notoginseng, 7-11 parts of safflower, 7-11 parts of peach kernel, 7-11 parts of eucommia, 7-11 parts of dried tangerine peel, 7-10 parts of radix aconiti preparata, and 7-10 parts of processed radix aconiti kusnezoffii. The pharmaceutical composition provided by the invention can reach quick swelling diminishing and pain relieving on various closed soft tissue injuries, and promote soft tissue's quick restoration of normal functions, has an effective rate up to 100% on acute sprain and contusion, muscle strain, and articular ligament strain, the cure rate is up to 100%, the course of treatment is short, usually swelling can be eliminated within 24 hours, and full-recovery can be achieved within one week. For chronic tenosynovitis and periarthritis of shoulder, the effective rate is up to 100%, and the cure rate is up 95% or more. With the characteristics of exact curative effect, small toxic and side effect and low cost, the pharmaceutical composition can greatly mitigate patients' financial burden and mental burden.

Description

technical field [0001] The invention relates to the technical field of medicines, in particular to a pharmaceutical composition for treating soft tissue injuries. Background technique [0002] Soft tissue injury is the most common disease in the Department of Orthopedics and Traumatology. It generally refers to a large category of trauma syndromes caused by direct or indirect violence on soft tissues or skeletal muscles, or long-term chronic strain; Bacterial inflammation, resulting in local swelling and pain, unfavorable activities, also known as "injured tendons" in traditional Chinese medicine. [0003] Soft tissue injuries are divided into two categories: open soft tissue injuries and closed soft tissue injuries. Closed soft tissue injuries refer to local skin or mucous membranes that are intact and have no gaps to communicate with the outside world. Injuries are often accompanied by internal bleeding, interstitial fluid exudation, and formation of localized soft tissue ...

AI Technical Summary

Problems solved by technology

[0005] The current treatment methods generally have the following problems: the treatment time is long, especially for more serious soft tissue injuries and chronic soft tissue injuries, the course of treatment is often as long as half a year or even a year, and the treatment is not thorough, leaving some sequelae, affecting the normal life of the patient. Work and life, and the cost of treatment is high, with varying degrees of toxic and side effects, such as the aforementioned patent application, the patent has as many as 20 components, its safety is questionable, and the curative effect needs to be further improved

Chronic soft tissue injuries such as tenosynovitis and frozen shoulder are less effective and very prone to recurrence